The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers

Thrombosis and Haemostasis

Volumn 81, Issue 5, 1999, Pages 758-762

  Lawrie, A S ^a   Mackie, I J ^a   Purdy, G ^a   Machin, S J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ECARIN; HEPARIN; LUPUS ANTICOAGULANT; REAGENT; VIPER VENOM;

ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; HEPARINIZATION; HUMAN; ORAL DRUG ADMINISTRATION; PLASMA; PRIORITY JOURNAL; TECHNIQUE;

EID: 0032915459     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614567     Document Type: Article

References (18)

1. Harris EN. Syndrome of the black swan. Br J Rheumatol 1987; 26: 324-6.
2. Asherson RA, Khamsahta MA, Ordi Ros J, Derksen RH, Machin SJ, Barquinero J, Outt HH, Harris EN, Vilardell Torres M, Hughes GR. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine 1989; 68: 366-74.
3. Shapiro SS. The lupus anticoagulant/antiphospholipid syndrome. Annual Review of Medicine 1996; 47: 533-53.
4. Harris EN, Pierangeli SS. Anticardiolipin and lupus anticoagulant testing and significance. J Clin Immunoassay 1994; 17: 108-17.
5. Pauzner R, Rosner E, Many A. Circulating anticoagulant in systemic lupus erythematosus: clinical manifestations. Acta Haematologica 1986; 76: 90-4.
6. Conley CL, Hartmann RC. Haemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Investig 1952; 31: 621-2.
7. Roubey RAS, Hoffman M. From antiphospholipid syndrome to antibody-mediated thrombosis. Lancet 1997; 350: 1491-3.
8. Carreras LO, Forastiero RR. Pathogenic role of antiprotein-phospholipid antibodies. Haemostasis 1996; 26 (Suppl. 4): 340-57.
9. British Society for Haematology: Guidelines on testing for lupus anticoagulant. J Clin Pathol 1991; 44: 885-9.
10. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulant: An update. Thromb Haemost 1995; 74: 1185-90.
11. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russell's viper venom time for the diagnosis of lupus anticoagulant. Blood 1986; 68: 869-74.
12. UK National External Quality Assessment Scheme for Blood Coagulation. Report on Surveys 92 & 93 (1995)
13. Triplett DA, Stocker KF, Unger GA, Barna LK. The Textarin/Ecarin ratio: a confirmatory test for lupus anticoagulant. Thromb Haemost 1993; 70: 925-31.
14. Rooney AM, McNally T, Mackie IJ, Machin SJ. The Taipan snake venom time: a new test for lupus anticoagulant. J Clin Pathol.1994; 47: 497-501
15. Lawrie AS, Purdy G, Mackie IJ, Machin SJ. Monitoring of oral anticoagulation therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome. Br J Haematol 1997; 98: 887-92.
16. Three lupus anticoagulant kits. Medical Devices Agency Evaluation Report. MDA/98/43.
17. Wenzel E, Grillmeier P Strategies for the scientific definition of the terms "reliability" and "predictability" of clinical and laboratory findings. Haemostasis 1985; 15: 5-6
18. Jennings I, Kitchen S, Woods TAL, Preston FE, Greaves M (on behalf of the UK National External Quality Assessment Scheme for Blood Coagulation). Potentially clinically important inaccuracies in testing for the lupus anticoagulant: An analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation. Throm Haemost 1997; 77: 934-7.